Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science

Hypertension, which directly threatens quality of life, is a major contributor to cardiovascular and cerebrovascular events. Over the past two decades, domestic and foreign scholars have agreed upon various standards in the treatment of hypertension, and considerable progress has been made in the fi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hypertension research Ročník 36; číslo 7; s. 570
Hlavní autoři: Xiong, Xingjiang, Yang, Xiaochen, Liu, Yongmei, Zhang, Yun, Wang, Pengqian, Wang, Jie
Médium: Journal Article
Jazyk:angličtina
Vydáno: England 01.07.2013
Témata:
ISSN:1348-4214, 1348-4214
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Hypertension, which directly threatens quality of life, is a major contributor to cardiovascular and cerebrovascular events. Over the past two decades, domestic and foreign scholars have agreed upon various standards in the treatment of hypertension, and considerable progress has been made in the field of antihypertensive drugs. Oral antihypertensive drugs represent a milestone in hypertension therapy. However, the blood pressure standard for patients with hypertension is far from satisfactory. The study of Chinese herbal formulas for treating hypertension has received much research attention. These studies seek to integrate traditional and Western medicine in China. Currently, Chinese herbal formulas are known to have an outstanding advantage with regard to bodily regulation. Research shows that Chinese medicine has many protective mechanisms. This paper addresses the process of the antihypertensive mechanisms in Chinese herbal formulas for treating hypertension. These mechanisms are to be discussed in future research.
AbstractList Hypertension, which directly threatens quality of life, is a major contributor to cardiovascular and cerebrovascular events. Over the past two decades, domestic and foreign scholars have agreed upon various standards in the treatment of hypertension, and considerable progress has been made in the field of antihypertensive drugs. Oral antihypertensive drugs represent a milestone in hypertension therapy. However, the blood pressure standard for patients with hypertension is far from satisfactory. The study of Chinese herbal formulas for treating hypertension has received much research attention. These studies seek to integrate traditional and Western medicine in China. Currently, Chinese herbal formulas are known to have an outstanding advantage with regard to bodily regulation. Research shows that Chinese medicine has many protective mechanisms. This paper addresses the process of the antihypertensive mechanisms in Chinese herbal formulas for treating hypertension. These mechanisms are to be discussed in future research.Hypertension, which directly threatens quality of life, is a major contributor to cardiovascular and cerebrovascular events. Over the past two decades, domestic and foreign scholars have agreed upon various standards in the treatment of hypertension, and considerable progress has been made in the field of antihypertensive drugs. Oral antihypertensive drugs represent a milestone in hypertension therapy. However, the blood pressure standard for patients with hypertension is far from satisfactory. The study of Chinese herbal formulas for treating hypertension has received much research attention. These studies seek to integrate traditional and Western medicine in China. Currently, Chinese herbal formulas are known to have an outstanding advantage with regard to bodily regulation. Research shows that Chinese medicine has many protective mechanisms. This paper addresses the process of the antihypertensive mechanisms in Chinese herbal formulas for treating hypertension. These mechanisms are to be discussed in future research.
Hypertension, which directly threatens quality of life, is a major contributor to cardiovascular and cerebrovascular events. Over the past two decades, domestic and foreign scholars have agreed upon various standards in the treatment of hypertension, and considerable progress has been made in the field of antihypertensive drugs. Oral antihypertensive drugs represent a milestone in hypertension therapy. However, the blood pressure standard for patients with hypertension is far from satisfactory. The study of Chinese herbal formulas for treating hypertension has received much research attention. These studies seek to integrate traditional and Western medicine in China. Currently, Chinese herbal formulas are known to have an outstanding advantage with regard to bodily regulation. Research shows that Chinese medicine has many protective mechanisms. This paper addresses the process of the antihypertensive mechanisms in Chinese herbal formulas for treating hypertension. These mechanisms are to be discussed in future research.
Author Liu, Yongmei
Wang, Pengqian
Xiong, Xingjiang
Yang, Xiaochen
Zhang, Yun
Wang, Jie
Author_xml – sequence: 1
  givenname: Xingjiang
  surname: Xiong
  fullname: Xiong, Xingjiang
  email: 5administration@163.com
  organization: Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. 5administration@163.com
– sequence: 2
  givenname: Xiaochen
  surname: Yang
  fullname: Yang, Xiaochen
– sequence: 3
  givenname: Yongmei
  surname: Liu
  fullname: Liu, Yongmei
– sequence: 4
  givenname: Yun
  surname: Zhang
  fullname: Zhang, Yun
– sequence: 5
  givenname: Pengqian
  surname: Wang
  fullname: Wang, Pengqian
– sequence: 6
  givenname: Jie
  surname: Wang
  fullname: Wang, Jie
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23552514$$D View this record in MEDLINE/PubMed
BookMark eNpNkE1LxDAQhoOsuB968QdIjl665nNNvcniFyx40XNJk4mNtGlNWmH_vRF3wdM8wzzzwswSzUIfAKFLStaUcHXTxDUjlK-pOkELyoUqBKNi9o_naJnSJyFMyZKeoTnjUjJJxQIN28YHSIAbiLVusetjN7U6_QIeI-jRhw_c7AeII4Tk-4B9yANt_ZibvHEM6MB6k_EOZzcNYEb_Dbh3uOstxICT8RAMnKNTp9sEF4e6Qu-PD2_b52L3-vSyvd8VRmzUWDCQ7LbccKsYJ4QKReoauOOiFpppomoAzjh1wlpCtATLjLG1YLIsuXaOshW6_ssdYv81QRqrzicDbasD9FOqKC-V4JJsyqxeHdSpzldUQ_Sdjvvq-CX2A0ygbC8
CitedBy_id crossref_primary_10_1016_j_ctim_2015_04_002
crossref_primary_10_3390_ijms15046641
crossref_primary_10_1155_2014_418206
crossref_primary_10_1097_HJH_0000000000002675
crossref_primary_10_1155_2015_601067
crossref_primary_10_1155_2014_963208
crossref_primary_10_1016_j_eujim_2019_100945
crossref_primary_10_1016_j_ctim_2015_04_008
crossref_primary_10_3389_fcvm_2021_627741
crossref_primary_10_3389_fphar_2023_1093669
crossref_primary_10_1016_j_biopha_2021_111941
crossref_primary_10_1111_bcp_13013
crossref_primary_10_1007_s11655_014_1709_6
crossref_primary_10_1155_2014_537014
crossref_primary_10_1155_2016_1592731
crossref_primary_10_1142_S0192415X17500641
crossref_primary_10_1016_S2095_4964_14_60058_3
crossref_primary_10_1590_s2175_97902017000300215
crossref_primary_10_1161_CIRCULATIONAHA_120_046685
crossref_primary_10_1038_s41598_017_04661_1
crossref_primary_10_1080_10641963_2021_2013491
crossref_primary_10_3389_fphar_2022_1014410
crossref_primary_10_1111_cns_13724
crossref_primary_10_1155_2013_978398
crossref_primary_10_3892_mmr_2015_4095
crossref_primary_10_1136_bmjopen_2014_005355
crossref_primary_10_1155_2013_262685
crossref_primary_10_1186_s13020_021_00446_x
crossref_primary_10_3390_molecules19044791
crossref_primary_10_1371_journal_pone_0316276
crossref_primary_10_1142_S0192415X18500167
crossref_primary_10_1080_17445760_2019_1606912
crossref_primary_10_1155_2013_493521
crossref_primary_10_1155_2014_204840
crossref_primary_10_1097_MD_0000000000000442
crossref_primary_10_1155_2022_7345116
crossref_primary_10_1038_s41440_021_00682_6
crossref_primary_10_1136_bmjopen_2021_059805
crossref_primary_10_1155_2020_3439191
crossref_primary_10_1016_j_jep_2015_04_046
crossref_primary_10_1155_2013_948319
crossref_primary_10_1155_2015_349721
crossref_primary_10_1161_CIRCOUTCOMES_121_007923
crossref_primary_10_1186_s12906_020_03068_2
crossref_primary_10_1093_ajh_hpaf057
crossref_primary_10_3109_02652048_2015_1094532
crossref_primary_10_1007_s00404_015_3766_2
crossref_primary_10_1016_j_phrs_2019_01_018
crossref_primary_10_1089_omi_2018_0074
crossref_primary_10_1186_s12906_015_0690_8
crossref_primary_10_1089_jmf_2016_3836
crossref_primary_10_1093_chromsci_bmv246
crossref_primary_10_2147_DDDT_S490652
crossref_primary_10_3389_fphar_2021_638298
crossref_primary_10_1155_2022_3353464
crossref_primary_10_3892_etm_2021_11033
crossref_primary_10_1016_j_phymed_2014_12_013
crossref_primary_10_1186_s12906_016_1421_5
crossref_primary_10_1186_s12906_017_1674_7
crossref_primary_10_1142_S0192415X18500507
crossref_primary_10_1155_2024_2226143
crossref_primary_10_3389_fphar_2023_1225529
crossref_primary_10_1016_j_jep_2023_117121
crossref_primary_10_3389_fphar_2020_00909
crossref_primary_10_1002_tox_22589
crossref_primary_10_1186_s13063_021_05650_6
crossref_primary_10_1155_2013_706125
crossref_primary_10_1016_j_phrs_2021_105639
crossref_primary_10_1080_10408398_2015_1018987
crossref_primary_10_1016_j_jep_2024_118193
crossref_primary_10_3389_fphar_2020_00345
crossref_primary_10_1136_bmjopen_2014_006502
crossref_primary_10_1155_2014_804171
crossref_primary_10_1155_2015_393510
crossref_primary_10_1155_2014_473038
crossref_primary_10_3389_fphar_2018_00668
crossref_primary_10_1016_j_ctim_2014_12_008
crossref_primary_10_1016_j_jep_2014_07_047
crossref_primary_10_1080_10641963_2016_1200603
crossref_primary_10_1155_2014_809741
crossref_primary_10_1016_j_phymed_2019_152849
crossref_primary_10_1155_2013_956397
crossref_primary_10_1016_j_phymed_2014_04_024
crossref_primary_10_1155_2014_187484
crossref_primary_10_1136_bmjopen_2014_007291
crossref_primary_10_1016_j_atherosclerosis_2015_01_025
crossref_primary_10_1186_s12906_015_0889_8
crossref_primary_10_1155_2019_3171420
crossref_primary_10_1155_2016_4723530
crossref_primary_10_1038_hr_2013_15
crossref_primary_10_1155_2015_143145
crossref_primary_10_1007_s11655_018_3009_2
crossref_primary_10_1155_2014_242589
crossref_primary_10_1097_MD_0000000000021674
crossref_primary_10_2147_AABC_S392878
crossref_primary_10_1515_tnsci_2020_0185
crossref_primary_10_1016_j_jksus_2023_102913
crossref_primary_10_1007_s11030_014_9521_y
crossref_primary_10_1142_S0192415X20500639
crossref_primary_10_1007_s11655_017_2771_7
crossref_primary_10_1155_2013_275279
crossref_primary_10_1016_j_maturitas_2015_01_002
crossref_primary_10_1155_2018_2958717
crossref_primary_10_1186_s13063_022_07006_0
crossref_primary_10_1097_MD_0000000000000352
crossref_primary_10_1186_s12929_017_0357_5
crossref_primary_10_1016_j_hermed_2016_06_001
crossref_primary_10_3390_nu7075220
crossref_primary_10_1007_s11655_016_2277_8
crossref_primary_10_1016_j_ctim_2013_11_005
crossref_primary_10_1186_s13020_021_00431_4
crossref_primary_10_1186_s13063_020_04395_y
crossref_primary_10_13005_bpj_3048
crossref_primary_10_1038_jhh_2014_52
crossref_primary_10_3389_fphar_2020_00600
crossref_primary_10_1155_2020_7503605
crossref_primary_10_1186_s13643_019_1218_y
crossref_primary_10_1155_2013_215254
crossref_primary_10_1016_j_jep_2022_115933
crossref_primary_10_1155_2014_976713
crossref_primary_10_3389_fphar_2022_1025104
crossref_primary_10_1002_bmc_3751
crossref_primary_10_1016_j_atherosclerosis_2018_08_039
crossref_primary_10_1186_s13020_021_00507_1
crossref_primary_10_1097_MD_0000000000001850
crossref_primary_10_1016_S0254_6272_17_30053_5
crossref_primary_10_1038_s41598_019_52309_z
crossref_primary_10_1155_2015_309261
crossref_primary_10_1016_j_jep_2021_113791
crossref_primary_10_1093_chromsci_bmv031
crossref_primary_10_1038_s41598_025_01022_1
crossref_primary_10_1155_2014_187979
crossref_primary_10_1136_bmjopen_2018_025218
crossref_primary_10_1155_2015_358352
crossref_primary_10_1186_s13020_024_01022_9
crossref_primary_10_3390_polym10111198
crossref_primary_10_1155_2017_9493076
crossref_primary_10_1155_2020_6701272
crossref_primary_10_3390_ijms19061638
crossref_primary_10_1155_2014_745919
crossref_primary_10_1155_2020_9326948
crossref_primary_10_1155_2013_757540
crossref_primary_10_1155_2020_8870148
crossref_primary_10_3389_fphar_2020_00823
crossref_primary_10_1038_srep42965
crossref_primary_10_3389_fphar_2020_00383
crossref_primary_10_1186_s13063_022_06089_z
crossref_primary_10_3389_fphar_2018_00466
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1038/hr.2013.18
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1348-4214
ExternalDocumentID 23552514
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
-Q-
.55
0R~
29I
2WC
39C
4.4
406
53G
5GY
70F
7X7
88E
8FI
8FJ
AACDK
AANZL
AASML
AATNV
ABAKF
ABAWZ
ABBRH
ABDBE
ABFSG
ABJNI
ABLJU
ABRTQ
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACRQY
ACSTC
ACZOJ
ADBBV
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ATHPR
AXYYD
AYFIA
BAWUL
BENPR
BKKNO
BPHCQ
BVXVI
CCPQU
CGR
CS3
CUY
CVF
DIK
DNIVK
DPUIP
DU5
E3Z
EBLON
EBS
ECM
EE.
EIF
EIOEI
EJD
EMB
EMOBN
F5P
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GX1
HMCUK
HZ~
IWAJR
JSF
JSH
JSO
JZLTJ
KQ8
LGEZI
LOTEE
M1P
NADUK
NPM
NQJWS
NXXTH
O9-
OK1
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
RJT
RNT
RNTTT
ROL
RZJ
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TKC
TR2
TSG
UKHRP
W2D
X7M
XSB
7X8
ID FETCH-LOGICAL-c468t-2e527963d823001480bbe3f34b4a2a08bee3231f4dd00a5ed2ccdb425993aff12
IEDL.DBID 7X8
ISICitedReferencesCount 161
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000321426300002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1348-4214
IngestDate Thu Oct 02 21:15:29 EDT 2025
Mon Jul 21 06:05:25 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c468t-2e527963d823001480bbe3f34b4a2a08bee3231f4dd00a5ed2ccdb425993aff12
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.nature.com/articles/hr201318.pdf
PMID 23552514
PQID 1398435069
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1398435069
pubmed_primary_23552514
PublicationCentury 2000
PublicationDate 2013-07-01
PublicationDateYYYYMMDD 2013-07-01
PublicationDate_xml – month: 07
  year: 2013
  text: 2013-07-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Hypertension research
PublicationTitleAlternate Hypertens Res
PublicationYear 2013
References 16880345 - Hypertension. 2006 Sep;48(3):397-403
11530112 - Cardiovasc Res. 2001 Sep;51(4):784-91
21390571 - Chin J Integr Med. 2011 Feb;17(2):83-4
21860391 - Nat Rev Mol Cell Biol. 2011 Sep;12(9):551-64
21091365 - Clin Exp Hypertens. 2010;32(8):491-8
11747386 - Ann Intern Med. 2001 Dec 18;135(12):1074-8
23533493 - Evid Based Complement Alternat Med. 2013;2013:540613
20602794 - BMC Cardiovasc Disord. 2010;10:33
18685604 - J Hum Hypertens. 2008 Dec;22(12):829-37
17913414 - J Ethnopharmacol. 2007 Dec 3;114(3):458-62
22550539 - Evid Based Complement Alternat Med. 2012;2012:268542
15353025 - J Altern Complement Med. 2004 Aug;10(4):675-80
9449393 - Hypertension. 1998 Jan;31(1):68-72
19583930 - Zhong Xi Yi Jie He Xue Bao. 2009 Jun;7(6):509-13
21066891 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Oct;30(10):1061-6
17620944 - J Hypertens. 2007 Aug;25(8):1525-32
12584789 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Apr;22(4):274-6
20473732 - Chin J Integr Med. 2010 Apr;16(2):100-1
22696374 - Cochrane Database Syst Rev. 2012;6:CD008166
12585150 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Feb;22(2):122-5
23320025 - Evid Based Complement Alternat Med. 2012;2012:271462
15768872 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Feb;25(2):114-8
12585164 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Jan;22(1):18-20
20828224 - Clin Exp Hypertens. 2010;32(7):423-5
21660675 - Chin J Integr Med. 2011 Jun;17(6):414-20
19548441 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Mar;29(3):233-7
21690504 - Circulation. 2011 Jun 21;123(24):2892-6
19022154 - J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57
18843743 - Cochrane Database Syst Rev. 2008;(4):CD007066
12592690 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Jul;22(7):528-30
20400620 - Cardiovasc Res. 2010 Jul 15;87(2):262-71
20669673 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Apr;30(4):376-9
22821652 - Chin J Integr Med. 2012 Jun;18(6):403-4
18853108 - Chin J Integr Med. 2008 Sep;14(3):163-4
22194771 - Evid Based Complement Alternat Med. 2012;2012:284847
14714358 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003 Dec;23(12):898-901
18695203 - Circulation. 2008 Aug 12;118(7):773-84
20546847 - Fitoterapia. 2010 Oct;81(7):844-8
20180771 - Curr Vasc Pharmacol. 2010 May;8(3):344-62
16942927 - Am J Hypertens. 2006 Sep;19(9):880-6
17302058 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Jan;27(1):21-4
18172057 - Hypertension. 2008 Feb;51(2):360-6
12409955 - J Hypertens. 2002 Nov;20(11):2173-82
18199020 - J Altern Complement Med. 2008 Jan-Feb;14(1):3-7
17762664 - J Hypertens. 2007 Sep;25(9):1974-5
11416667 - J Clin Hypertens (Greenwich). 2000 Oct;2(5):312-318
21110171 - Chin J Integr Med. 2010 Dec;16(6):483-5
17015784 - Hypertension. 2006 Nov;48(5):838-45
16288809 - Pharmacol Ther. 2006 Jul;111(1):81-98
15998708 - Hypertension. 2005 Aug;46(2):406-11
11967245 - Hypertension. 2002 Apr;39(4):892-6
11807965 - Phytother Res. 2002 Feb;16(1):48-54
22283776 - Curr Pharm Des. 2012;18(7):971-80
20073225 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Oct;29(10):918-21
11794147 - N Engl J Med. 2001 Nov 1;345(18):1291-7
21258892 - Chin J Integr Med. 2011 Jan;17(1):21-5
12943180 - Am J Chin Med. 2003;31(3):489-97
19065898 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Sep;28(9):824-7
19848195 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Aug;29(8):680-4
21563512 - J Tradit Chin Med. 2011 Mar;31(1):69-72
21682890 - Chin Med. 2011 Jun 17;6(1):23
19635987 - Hypertension. 2009 Sep;54(3):462-4
15664381 - Cardiovasc Res. 2005 Feb 15;65(3):550-63
14656957 - Hypertension. 2003 Dec;42(6):1206-52
18784133 - Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v23-4
16185775 - Trends Pharmacol Sci. 2005 Nov;26(11):558-63
23346210 - Evid Based Complement Alternat Med. 2012;2012:697237
21053621 - J Tradit Chin Med. 2010 Sep;30(3):171-5
23575381 - Hypertens Res. 2013 Jul;36(7):583-5
21029339 - J Clin Hypertens (Greenwich). 2010 Oct;12(10):765-75
22466938 - Chin J Integr Med. 2012 Mar;18(3):164-5
8607422 - Am J Cardiol. 1996 Feb 1;77(4):325
23573163 - Evid Based Complement Alternat Med. 2013;2013:982380
22281657 - Curr Atheroscler Rep. 2012 Apr;14(2):160-6
20694775 - Chin J Integr Med. 2010 Jun;16(3):216-21
10556973 - Cell Death Differ. 1999 Oct;6(10):964-8
20697946 - Chin J Integr Med. 2010 Aug;16(4):344-7
19602720 - J Clin Pharmacol. 2009 Aug;49(8):947-56
20557410 - J Eval Clin Pract. 2010 Aug;16(4):818-24
18543391 - Am J Chin Med. 2008;36(3):593-602
15892283 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Apr;25(4):350-3
20033075 - J Hum Hypertens. 2010 Sep;24(9):600-8
23258998 - Evid Based Complement Alternat Med. 2012;2012:714805
12466042 - Acta Pharmacol Sin. 2002 Dec;23(12):1057-68
References_xml – reference: 11747386 - Ann Intern Med. 2001 Dec 18;135(12):1074-8
– reference: 21682890 - Chin Med. 2011 Jun 17;6(1):23
– reference: 11967245 - Hypertension. 2002 Apr;39(4):892-6
– reference: 21029339 - J Clin Hypertens (Greenwich). 2010 Oct;12(10):765-75
– reference: 14656957 - Hypertension. 2003 Dec;42(6):1206-52
– reference: 12466042 - Acta Pharmacol Sin. 2002 Dec;23(12):1057-68
– reference: 23258998 - Evid Based Complement Alternat Med. 2012;2012:714805
– reference: 18172057 - Hypertension. 2008 Feb;51(2):360-6
– reference: 21563512 - J Tradit Chin Med. 2011 Mar;31(1):69-72
– reference: 19583930 - Zhong Xi Yi Jie He Xue Bao. 2009 Jun;7(6):509-13
– reference: 15353025 - J Altern Complement Med. 2004 Aug;10(4):675-80
– reference: 18843743 - Cochrane Database Syst Rev. 2008;(4):CD007066
– reference: 21091365 - Clin Exp Hypertens. 2010;32(8):491-8
– reference: 12943180 - Am J Chin Med. 2003;31(3):489-97
– reference: 9449393 - Hypertension. 1998 Jan;31(1):68-72
– reference: 20828224 - Clin Exp Hypertens. 2010;32(7):423-5
– reference: 11530112 - Cardiovasc Res. 2001 Sep;51(4):784-91
– reference: 20400620 - Cardiovasc Res. 2010 Jul 15;87(2):262-71
– reference: 18853108 - Chin J Integr Med. 2008 Sep;14(3):163-4
– reference: 19065898 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Sep;28(9):824-7
– reference: 22281657 - Curr Atheroscler Rep. 2012 Apr;14(2):160-6
– reference: 19635987 - Hypertension. 2009 Sep;54(3):462-4
– reference: 16942927 - Am J Hypertens. 2006 Sep;19(9):880-6
– reference: 21390571 - Chin J Integr Med. 2011 Feb;17(2):83-4
– reference: 17015784 - Hypertension. 2006 Nov;48(5):838-45
– reference: 20473732 - Chin J Integr Med. 2010 Apr;16(2):100-1
– reference: 18199020 - J Altern Complement Med. 2008 Jan-Feb;14(1):3-7
– reference: 11794147 - N Engl J Med. 2001 Nov 1;345(18):1291-7
– reference: 12592690 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Jul;22(7):528-30
– reference: 22550539 - Evid Based Complement Alternat Med. 2012;2012:268542
– reference: 11416667 - J Clin Hypertens (Greenwich). 2000 Oct;2(5):312-318
– reference: 15998708 - Hypertension. 2005 Aug;46(2):406-11
– reference: 21690504 - Circulation. 2011 Jun 21;123(24):2892-6
– reference: 23573163 - Evid Based Complement Alternat Med. 2013;2013:982380
– reference: 20694775 - Chin J Integr Med. 2010 Jun;16(3):216-21
– reference: 21053621 - J Tradit Chin Med. 2010 Sep;30(3):171-5
– reference: 12409955 - J Hypertens. 2002 Nov;20(11):2173-82
– reference: 20180771 - Curr Vasc Pharmacol. 2010 May;8(3):344-62
– reference: 16185775 - Trends Pharmacol Sci. 2005 Nov;26(11):558-63
– reference: 20557410 - J Eval Clin Pract. 2010 Aug;16(4):818-24
– reference: 17302058 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Jan;27(1):21-4
– reference: 21660675 - Chin J Integr Med. 2011 Jun;17(6):414-20
– reference: 20697946 - Chin J Integr Med. 2010 Aug;16(4):344-7
– reference: 22821652 - Chin J Integr Med. 2012 Jun;18(6):403-4
– reference: 18784133 - Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v23-4
– reference: 21860391 - Nat Rev Mol Cell Biol. 2011 Sep;12(9):551-64
– reference: 20073225 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Oct;29(10):918-21
– reference: 8607422 - Am J Cardiol. 1996 Feb 1;77(4):325
– reference: 20033075 - J Hum Hypertens. 2010 Sep;24(9):600-8
– reference: 22194771 - Evid Based Complement Alternat Med. 2012;2012:284847
– reference: 18685604 - J Hum Hypertens. 2008 Dec;22(12):829-37
– reference: 14714358 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003 Dec;23(12):898-901
– reference: 20669673 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Apr;30(4):376-9
– reference: 18543391 - Am J Chin Med. 2008;36(3):593-602
– reference: 19848195 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Aug;29(8):680-4
– reference: 17762664 - J Hypertens. 2007 Sep;25(9):1974-5
– reference: 15664381 - Cardiovasc Res. 2005 Feb 15;65(3):550-63
– reference: 11807965 - Phytother Res. 2002 Feb;16(1):48-54
– reference: 15892283 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Apr;25(4):350-3
– reference: 16880345 - Hypertension. 2006 Sep;48(3):397-403
– reference: 10556973 - Cell Death Differ. 1999 Oct;6(10):964-8
– reference: 22696374 - Cochrane Database Syst Rev. 2012;6:CD008166
– reference: 21066891 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Oct;30(10):1061-6
– reference: 23320025 - Evid Based Complement Alternat Med. 2012;2012:271462
– reference: 12584789 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Apr;22(4):274-6
– reference: 17620944 - J Hypertens. 2007 Aug;25(8):1525-32
– reference: 15768872 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Feb;25(2):114-8
– reference: 20546847 - Fitoterapia. 2010 Oct;81(7):844-8
– reference: 16288809 - Pharmacol Ther. 2006 Jul;111(1):81-98
– reference: 17913414 - J Ethnopharmacol. 2007 Dec 3;114(3):458-62
– reference: 21258892 - Chin J Integr Med. 2011 Jan;17(1):21-5
– reference: 23346210 - Evid Based Complement Alternat Med. 2012;2012:697237
– reference: 18695203 - Circulation. 2008 Aug 12;118(7):773-84
– reference: 22466938 - Chin J Integr Med. 2012 Mar;18(3):164-5
– reference: 19548441 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Mar;29(3):233-7
– reference: 19022154 - J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57
– reference: 22283776 - Curr Pharm Des. 2012;18(7):971-80
– reference: 12585150 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Feb;22(2):122-5
– reference: 19602720 - J Clin Pharmacol. 2009 Aug;49(8):947-56
– reference: 21110171 - Chin J Integr Med. 2010 Dec;16(6):483-5
– reference: 23575381 - Hypertens Res. 2013 Jul;36(7):583-5
– reference: 12585164 - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Jan;22(1):18-20
– reference: 20602794 - BMC Cardiovasc Disord. 2010;10:33
– reference: 23533493 - Evid Based Complement Alternat Med. 2013;2013:540613
SSID ssj0028591
Score 2.459858
SecondaryResourceType review_article
Snippet Hypertension, which directly threatens quality of life, is a major contributor to cardiovascular and cerebrovascular events. Over the past two decades,...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 570
SubjectTerms Drugs, Chinese Herbal - pharmacology
Drugs, Chinese Herbal - therapeutic use
Endothelial Cells - drug effects
Endothelial Cells - physiology
Humans
Hypertension - drug therapy
Insulin Resistance
Lipid Metabolism - drug effects
Medicine, Chinese Traditional
Phytotherapy
Renin-Angiotensin System - drug effects
Sympathetic Nervous System - drug effects
Title Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science
URI https://www.ncbi.nlm.nih.gov/pubmed/23552514
https://www.proquest.com/docview/1398435069
Volume 36
WOSCitedRecordID wos000321426300002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAIsTC-1FeMhKraWI7acKCEKJioFUHQN0iP9UOJKFp-f2cnYROSEgsUaTYVmTf-T7fne9D6CamgidWRETFVBNOVUqk5BFhacgjqSzlPtvi_aU_GiWTSTpuHG5Vk1bZ7ol-o9aFcj7yHiCVBEx7EKf35SdxrFEuutpQaKyjDoMGTqr7k58ogq_N5g9czmlGQ96WJ2VJb-pqgYbsNkx-h5bexAx2__tze2inAZf4oZaGfbRm8gO0NWzC54eodGzZpjIYFkpCQwdYlwCf3Qv2KedgyPAUjqZzn9he5HiWwwehZ7XLELcDtCH5O1yubmviwuIPz62GG8N6hN4GT6-Pz6ShXCCKx8mCUBPRPuikdvE352wMpDTMMi65oCJIpDEMEKHlWgeBiIymSmkJeg8wR1gb0mO0kRe5OUU41cyEnGonBByGlWlkrXLV4jn0UKaLrtu5zECkXZxC5KZYVtlqNrvopF6QrKxrb2QU8BFAMn72h97naJt68gqXXHuBOhYU2lyiTfW1mFXzKy8r8ByNh98HucuU
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chinese+herbal+formulas+for+treating+hypertension+in+traditional+Chinese+medicine%3A+perspective+of+modern+science&rft.jtitle=Hypertension+research&rft.au=Xiong%2C+Xingjiang&rft.au=Yang%2C+Xiaochen&rft.au=Liu%2C+Yongmei&rft.au=Zhang%2C+Yun&rft.date=2013-07-01&rft.eissn=1348-4214&rft.volume=36&rft.issue=7&rft.spage=570&rft_id=info:doi/10.1038%2Fhr.2013.18&rft_id=info%3Apmid%2F23552514&rft_id=info%3Apmid%2F23552514&rft.externalDocID=23552514
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1348-4214&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1348-4214&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1348-4214&client=summon